M. Blake Ingle

M. Blake Ingle

Chairman at Alerion Biomedical, Inc.

81 year
Health Technology
Consumer Services
Finance

Profile

Dr. Ingle was formerly CEO of IMCERA Group, a Fortune 250 healthcare company.
He has over thirty years of healthcare experience, including CEO of Canji, a biotech company that was sold to Schering-Plough in a successful transition for its venture capital investors.
Dr. Ingle also serves on the Board of Directors of Vical, Dendreon Corporation, Cengent Therapeutics, Alerion, Targeted Molecules Corp., INEX Pharmaceuticals, and serves as Strategic Advisor for Quorex Pharmaceuticals, and is a recent past Chairman of the Burnham Institute (formerly the La Jolla Cancer Research Foundation).
Dr. Ingle received a BS degree from Lewis University and an MS degree and a PhD from Colorado State University.

M. Blake Ingle active positions

CompaniesPositionStart
Chairman -
All active positions of M. Blake Ingle

Former positions of M. Blake Ingle

CompaniesPositionEnd
DENDREON CORPORATION Director/Board Member 09/06/2009
BRIDGETECH HOLDINGS INTERNATIONAL I(NDA) Director/Board Member 13/04/2008
President 31/01/1996
President 31/12/1992
Corvas International, Inc. Chairman -
See the detail of M. Blake Ingle's experience

Training of M. Blake Ingle

Lewis University Undergraduate Degree
Colorado State University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of M. Blake Ingle's experience

Connections

32

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies9

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Corvas International, Inc.

Health Technology

Health Services

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. M. Blake Ingle